Hoth Therapeutics Valuation
| HOTH Stock | USD 0.98 0.05 5.38% |
Today, the firm appears to be undervalued. Hoth Therapeutics retains a regular Real Value of $1.95 per share. The prevalent price of the firm is $0.98. Our model calculates the value of Hoth Therapeutics from evaluating the firm fundamentals such as Return On Asset of -0.84, return on equity of -1.51, and Shares Owned By Insiders of 3.57 % as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Hoth Therapeutics' valuation include:
Undervalued
Today
Please note that Hoth Therapeutics' price fluctuation is very risky at this time. Calculation of the real value of Hoth Therapeutics is based on 3 months time horizon. Increasing Hoth Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Hoth Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hoth Stock. However, Hoth Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.98 | Real 1.95 | Target 5.0 | Hype 0.98 |
The intrinsic value of Hoth Therapeutics' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Hoth Therapeutics' stock price.
Estimating the potential upside or downside of Hoth Therapeutics helps investors to forecast how Hoth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hoth Therapeutics more accurately as focusing exclusively on Hoth Therapeutics' fundamentals will not take into account other important factors: When choosing an evaluation method for Hoth Therapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Hoth Therapeutics Cash |
|
Hoth Therapeutics Total Value Analysis
Hoth Therapeutics is currently anticipated to have valuation of 6.71 M with market capitalization of 14.46 M, debt of 31.07 K, and cash on hands of 11.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Hoth Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.71 M | 14.46 M | 31.07 K | 11.62 M |
Hoth Therapeutics Asset Utilization
One of the ways to look at asset utilization of Hoth is to check how much profit was generated for every dollar of assets it reports. Hoth Therapeutics retains a negative application of resources of -0.84 (percent), losing $0.008446 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Hoth Therapeutics shows how discouraging it operates for each dollar spent on its resources.Hoth Therapeutics Profitability Analysis
Based on Hoth Therapeutics' profitability indicators, Hoth Therapeutics may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Hoth Therapeutics' ability to earn profits and add value for shareholders.Net Loss | First Reported 2017-06-30 | Previous Quarter -2.2 M | Current Value -4.1 M | Quarterly Volatility 1.1 M |
For Hoth Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hoth Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hoth Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hoth Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hoth Therapeutics over time as well as its relative position and ranking within its peers.
Hoth Therapeutics Earnings per Share Projection vs Actual
By analyzing Hoth Therapeutics' earnings estimates, investors can diagnose different trends across Hoth Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Hoth Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.Hoth Therapeutics Ownership Allocation
Hoth Therapeutics has a total of 15.51 Million outstanding shares. Hoth Therapeutics retains 3.57 (percent) of its outstanding shares held by insiders and 8.3 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Hoth Therapeutics Profitability Analysis
Net Loss for the year was (8.19 M) with profit before overhead, payroll, taxes, and interest of 0.About Hoth Therapeutics Valuation
An absolute valuation paradigm, as applied to Hoth Stock, attempts to find the value of Hoth Therapeutics based on its fundamental and basic technical indicators. By analyzing Hoth Therapeutics's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Hoth Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hoth Therapeutics. We calculate exposure to Hoth Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hoth Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -60.2 K | -63.2 K |
Hoth Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Hoth Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Hoth we look at many different elements of the entity such as Hoth's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Hoth Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Hoth Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Hoth Therapeutics' worth.Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |